Thailand Medical Food Market: By Product Type (Nutritionally Complete Formulas, Nutritionally Incomplete Formulas, Formulas for Metabolic Disorders, Oral Rehydration Products), By Demography (Infants, Children, adults), By Formulation (Pills, Powders, Liquid, Others), By Application (Sleep Management, Pain Management, Gastrointestinal Disorders, Neurological Disorders, Metabolic Disorders, Nutritional Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Country

Purchase Option

$ 3100
$ 4600
$ 6900

Medical foods are the dietary products that are specially formulated and used for the dietary management of disease that has unique nutritional feed and can't be met by routine diet. The ingredients used in the formulation of medical foods are must have generally recognized as safe (GRAS) status. These are completely different from dietary supplements, nutritional foods, and prescription drugs. Medicated foods contain nutrient-based ingredients such as chelated zinc, omega 3 fatty acids, and isoflavones, protein-based ingredients, vitamins, and minerals. 

Thailand's medical food market has a lucrative growth over the forecast years and country benefited from its medical service sector. Market players are focus to invest in Thailand medical food market owing to better availability of agriculture raw materials in the country, adoption of technological advancements, presence of skilled professionals and labors, and high quality-control standards. Moreover, government support for the investors in the country also surge the market. In addition, launch of newer food products and medical food production plants are bolster the Thailand medical food market. For instance, in October 2016, Thai Otsuka Pharmaceutical Co., Ltd. invested 650 Mn baht for the construction of new factory to produce the vital medicated foods.

Thailand Medical Food Market Dynamics

Increase in the prevalence of chronic diseases such as Alzheimer's, diabetes, neurological disorders, and renal failure is a key factor drives the Thailand medical food market. Moreover, favorable regulation scenario, rise in awareness about the medical foods among the people and healthcare professionals, rise in R&D for the development of newer products, launch of disease specific medicated food formulas by the market players, increase in the geriatric population, and rise in adoption of infant nutrition products are anticipated to propel the Thailand medical food market over the forecast years. However, high cost of products, lack of awareness about the proper usage, quality concerns, and strong scientific support to prove health claims are restrain the growth of Thailand medical food market.

Thailand Medical Food Market Segmentation

By Product Type
  • Nutritionally Complete Formulas
  • Nutritionally Incomplete Formulas
  • Formulas for Metabolic Disorders
  • Oral Rehydration Products
By Demography
  • Infants
  • Children
  • Adults
By Formulation
  • Pills
  • Powder
  • Liquid
  • Others
By Application
  • Sleep Management
  • Pain Management
  • Gastrointestinal Disorders
  • Neurological Disorders
  • Metabolic Disorders
  • Nutritional Disorders
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • NanoMed Co., Ltd. (Thailand)
  • Krittiya Royal Ltd. (Thailand)
  • Otsuka Pharmaceutical Co., Ltd. (Japan)
  • Abbott Laboratories (U.S.)
  • Danone (France)
  • Nestle S.A. (Switzerland)
  • Fresenius Kabi AG (Germany)
  • Mead Johnson Nutrition (U.S.)

Adjacent Markets